Key Takeaways
- Lumentum reached a 52-week peak of $1,072.70 following Citic Securities’ dramatic price target increase from $620 to $1,186.
- The optical component maker will enter the Nasdaq-100 index on May 18, taking CoStar Group’s (CSGP) place, triggering a 4.8% single-day surge.
- Several Wall Street firms elevated their targets, with Rosenblatt at $1,300, Raymond James at $1,014, and TD Cowen at $995, pushing the consensus to $1,012.43.
- Third-quarter results delivered $2.37 per share, surpassing the $2.27 forecast, while revenue climbed 90.1% annually to $808.4 million.
- Institutional stakeholders control 94.05% of shares, with significant Q4 positions established by Norges Bank and Value Aligned Research Advisors.
Lumentum (LITE) shares touched a new 52-week peak on Monday, climbing to $1,072.70 after a substantial analyst revision and confirmation of its imminent addition to the Nasdaq-100 index provided strong upward momentum from the previous close of $903.80.
Citic Securities emerged as the catalyst on the analyst side, dramatically elevating its price objective from $620 to $1,186 — representing more than a 90% jump. This revision arrived in tandem with multiple other upward adjustments announced last Wednesday.
Rosenblatt increased its forecast to $1,300 while maintaining a buy stance. Raymond James reiterated its outperform rating with a $1,014 projection. TD Cowen adjusted upward to $995, Barclays moved to $1,000, and UBS lifted its neutral-rated objective to $960. Among 20 Wall Street analysts tracking the stock, the overall rating stands at Moderate Buy with a mean target of $1,012.43.
The index membership announcement provided additional momentum. Nasdaq announced Friday that Lumentum will take CoStar Group’s (CSGP) spot in the benchmark index effective market open on May 18. Such developments typically generate mechanical buying from passive funds and exchange-traded products that replicate index compositions, and LITE responded with a 4.8% jump Monday.
Strong Quarterly Performance Fuels Confidence
The wave of analyst optimism stems from solid fundamentals. Lumentum unveiled Q3 fiscal 2026 results on May 5, posting $2.37 in earnings per share versus the Street’s $2.27 expectation — a $0.10 outperformance. Revenue totaled $808.4 million, narrowly missing the $810.21 million forecast but representing a robust 90.1% year-over-year expansion. The prior-year quarter produced just $0.57 per share.
For Q4 fiscal 2026, management projects EPS between $2.85 and $3.05. The Street currently models full-year earnings at $5.95 per share.
The photonics firm commands an $82.78 billion market capitalization, trades at a P/E multiple of 197.05, and exhibits a beta of 1.53. The 50-day moving average registers at $776.13, while the 200-day stands at $502.93 — highlighting the stock’s rapid ascent.
Major Institutional Accumulation
Beneath the surface, large investment firms have been accumulating aggressively. Arrowstreet Capital expanded its holdings by 8,579% during Q3, while Norges Bank established a fresh position valued at approximately $474.5 million in Q4. Value Aligned Research Advisors contributed roughly $432 million in new capital. Assenagon increased its stake by 707%. Institutional investors collectively control 94.05% of outstanding shares.
Insider transactions paint a contrasting picture. CFO Wajid Ali divested 5,302 shares in late February at $691.13 per share. Yuen Wupen sold 3,157 shares in mid-February at $538. Over the trailing 90 days, company insiders have sold 60,926 shares totaling approximately $36.25 million. Corporate insiders currently own just 0.43% of the enterprise.
The stock concluded Monday’s session at $1,061.43 on trading volume exceeding 5.7 million shares.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
